Total ankle replacement acquisition
This article was originally published in The Gray Sheet
Executive Summary
Small Bone Innovations picks up Link Orthopaedics' Scandinavian Total Ankle Replacement (S.T.A.R.) system in its Feb. 4 purchase for undisclosed terms of the firm from the German company Waldemar Link. The PMA-pending device, poised to become the "first and only FDA-approved, non-cemented mobile bearing total ankle replacement prosthesis," according to SBI, received an FDA panel endorsement in April 2007 (1"The Gray Sheet" April 30, 2007, p. 3). S.T.A.R. is intended as an alternative to fusion (arthrodesis) surgery to replace an ankle joint deformed by rheumatoid arthritis, primary arthritis or posttraumatic arthritis
You may also be interested in...
People In Brief
Spine start-up CEO: Long-time orthopedic executive Andrew Paul Greenberg is tapped as CEO of Disc Motion Technologies May 27 just as the firm's first product - the CE-marked True Total Spinal Motion Segment System - is being launched. The system is an all-in-one artificial lumbar disc, semi-rigid spine stabilization device and dynamic pedicle screw implanted via an incision in the back, rather than the more burdensome abdomen-initiated anterior approach required for other approved artificial discs, Disc Motion explains. Greenberg moves from his post as managing director of Link Orthopaedics, which is being acquired by Small Bone Innovations (1"The Gray Sheet" Feb. 11, 2008, In Brief). With Link, he was responsible for early development of the Charité artificial lumber disc before it was sold to Johnson & Johnson in 2003 and the PMA-pending S.T.A.R. total ankle replacement. Greenberg replaces Jud Carlson, who will remain on board as managing director of Disc Motion
Advisory Panel Recommends Approval For Link’s STAR Ankle Replacement
An FDA advisory panel recommended approval of Link Orthopedics' STAR ankle replacement system April 24 despite FDA reviewers' conclusion that results of the firm's pivotal trial are unclear
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.